Affiliation:
1. Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Kraków, Poland
Abstract
Pyrimidinylpiperazine anxiolytic drugs-ipsapirone, buspirone and gepirone-dose- dependently increased punished responding in an anticonflict (shock-induced suppression of drinking) paradigm in rats. Similar effect was also produced by their common metabolite 1- (2-pyrimidinyl)piperazine (1-PP). Anticonflict effects of ipsapirone, buspirone and gepirone, administered in maximal doses, were considerably stronger when tested 30 min than 120 min after their administration. Furthermore, anticonflict effects of these drugs, given in subthres hold or medium effective doses, were significantly potentiated by the non-selective drug metabolism inhibitor proadifen. Comparison of these results with literature pharmacokinetic data indicate that the pharmacological effect of ipsapirone, buspirone and gepirone parallels better cerebral concentrations of the parent drugs than 1-PP. Therefore anticonflict activity of the investigated drugs does not seem to be mediated by their common metabolite 1-PP.
Subject
Pharmacology (medical),Psychiatry and Mental health,Pharmacology
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anxiolytic-like effect of asiaticoside in mice;Pharmacology Biochemistry and Behavior;2006-10
2. Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression;Behavioural Pharmacology;2004-12
3. New Arylpiperazine 5-HT1A Receptor Ligands Containing the Pyrimido[2,1-f]purine Fragment: Synthesis, in Vitro, and in Vivo Pharmacological Evaluation;Journal of Medicinal Chemistry;2004-04-10
4. Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models;Neuropharmacology;1999-12
5. The novel buspirone analogue, 8-[4-[2-(1,2,3,4-tetrahydroisoquinolinyl) [butyl]-8 -azaspiro[4.5] decane-7,9 dione, with anxiolytic-like and antidepressant-like effects in rats;Journal of Psychopharmacology;1998-07